132 related articles for article (PubMed ID: 647693)
1. Tamoxifen retinopathy.
Kaiser-Kupfer MI; Lippman ME
Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693
[TBL] [Abstract][Full Text] [Related]
2. Retinal changes associated with tamoxifen treatment for breast cancer.
Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
[TBL] [Abstract][Full Text] [Related]
3. Tamoxifen retinopathy. A case report.
Costa RH; Dhooge MR; Van Wing F; De Rouck AF
Bull Soc Belge Ophtalmol; 1990; 238():161-8. PubMed ID: 2131119
[TBL] [Abstract][Full Text] [Related]
4. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Bourla DH; Sarraf D; Schwartz SD
Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
[TBL] [Abstract][Full Text] [Related]
5. Ocular toxicity of tamoxifen.
Gerner EW
Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
[TBL] [Abstract][Full Text] [Related]
6. Retinal changes associated with tamoxifen treatment for breast cancer.
Murray DC; Gibson JM
Eye (Lond); 1998; 12 ( Pt 3a)():485-6. PubMed ID: 9775258
[No Abstract] [Full Text] [Related]
7. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Adjuvant Tamoxifen Use on Macula Pigment Epithelium Optical Density, Visual Acuity and Retinal Thickness in Patients with Breast Cancer.
Bicer T; Imamoglu GI; Caliskan S; Bicer BK; Gurdal C
Curr Eye Res; 2020 May; 45(5):623-628. PubMed ID: 31684771
[No Abstract] [Full Text] [Related]
9. Optical coherence tomography findings in tamoxifen retinopathy.
Gualino V; Cohen SY; Delyfer MN; Sahel JA; Gaudric A
Am J Ophthalmol; 2005 Oct; 140(4):757-8. PubMed ID: 16226541
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-induced ocular toxicity.
Mihm LM; Barton TL
Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
[No Abstract] [Full Text] [Related]
11. Ocular assessment of patients treated with tamoxifen.
Beck M; Mills PV
Cancer Treat Rep; 1979; 63(11-12):1833-4. PubMed ID: 526917
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen retinopathy.
McKeown CA; Swartz M; Blom J; Maggiano JM
Br J Ophthalmol; 1981 Mar; 65(3):177-9. PubMed ID: 7225310
[TBL] [Abstract][Full Text] [Related]
13. Ocular toxicity in low-dose tamoxifen: a prospective study.
Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen retinopathy: a rare but serious complication.
Bentley CR; Davies G; Aclimandos WA
BMJ; 1992 Feb; 304(6825):495-6. PubMed ID: 1312376
[No Abstract] [Full Text] [Related]
15. Low-dose tamoxifen retinopathy.
Chang T; Gonder JR; Ventresca MR
Can J Ophthalmol; 1992 Apr; 27(3):148-9. PubMed ID: 1586887
[TBL] [Abstract][Full Text] [Related]
16. Delayed onset chloroquine retinopathy: case report.
Martin LJ; Bergen RL; Dobrow HR
Ann Ophthalmol; 1978 Jun; 10(6):723-6. PubMed ID: 677653
[TBL] [Abstract][Full Text] [Related]
17. [Is breast cancer prevention by tamoxifen possible?].
Namer M; Serin D; Ferrero JM
Bull Cancer; 1995 Jul; 82 Suppl 3():155s-167s. PubMed ID: 7492828
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen retinopathy: does it really exist?
Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
[TBL] [Abstract][Full Text] [Related]
19. [Ophthalmologic complications of low-dosage tamoxifen in the treatment of breast carcinoma].
de Jong-Busnac M
Ned Tijdschr Geneeskd; 1989 Mar; 133(10):514-6. PubMed ID: 2710233
[TBL] [Abstract][Full Text] [Related]
20. [Ophthalmologic complications of low-dose tamoxifen in the treatment of breast carcinoma].
Ned Tijdschr Geneeskd; 1989 Apr; 133(17):903-4. PubMed ID: 2725755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
